Presentation is loading. Please wait.

Presentation is loading. Please wait.

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements  E. Schaden, O. Kimberger, P. Kraincuk, D.M.

Published byDrusilla Dorsey Modified over 5 years ago

Similar presentations

Presentation on theme: "Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements  E. Schaden, O. Kimberger, P. Kraincuk, D.M."— Presentation transcript:

1 Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements  E. Schaden, O. Kimberger, P. Kraincuk, D.M. Baron, P.G. Metnitz, S. Kozek-Langenecker  British Journal of Anaesthesia  Volume 109, Issue 3, Pages (September 2012) DOI: /bja/aes186 Copyright © 2012 The Author(s) Terms and Conditions

2 Fig 1 Treatment algorithm. CT, clotting time; A 10, amplitude 10 min after CT; LY, lysis index 30 min after CT; FFP, fresh-frozen plasma; PCC, prothrombin complex concentrate. British Journal of Anaesthesia  , DOI: ( /bja/aes186) Copyright © 2012 The Author(s) Terms and Conditions

3 Fig 2 Transfusion requirements in the control and the algorithm group. Bar: median, whisker: range, *P<0.05 between the groups PRBC, packed red blood cells; FFP, fresh-frozen plasma; PC, platelet concentrate. British Journal of Anaesthesia  , DOI: ( /bja/aes186) Copyright © 2012 The Author(s) Terms and Conditions

Download ppt "Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements  E. Schaden, O. Kimberger, P. Kraincuk, D.M."

Similar presentations

Blood Bag Coagulation & Preservers Citrate 24 hours 1-6 ºC Heparin 48 hours 1-6 ºC ACD or CPD 21 days 1-6 ºC CPD-A135 days 1-6 ºC CPD-A1+ additive.

Blood Bag Coagulation & Preservers Citrate 24 hours 1-6 ºC Heparin 48 hours 1-6 ºC ACD or CPD 21 days 1-6 ºC CPD-A135 days 1-6 ºC CPD-A1+ additive.
From: First-line Therapy with Coagulation Factor Concentrates Combined with Point-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood.

From: First-line Therapy with Coagulation Factor Concentrates Combined with Point-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood.
Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy  N.

Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy  N.
D. M. Baron, P. G. H. Metnitz, T. Fellinger, B. Metnitz, A. Rhodes, S

D. M. Baron, P. G. H. Metnitz, T. Fellinger, B. Metnitz, A. Rhodes, S
Contemporary Bloodletting in Cardiac Surgical Care

Contemporary Bloodletting in Cardiac Surgical Care
J. W. Eikelboom, S. Kozek-Langenecker, A. Exadaktylos, A. Batorova, Z

J. W. Eikelboom, S. Kozek-Langenecker, A. Exadaktylos, A. Batorova, Z
Assessment of standard laboratory tests and rotational thromboelastometry for the prediction of postoperative bleeding in liver transplantation  T.M.

Assessment of standard laboratory tests and rotational thromboelastometry for the prediction of postoperative bleeding in liver transplantation  T.M.
Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program  Steve Xydas, MD, Christopher.

Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program  Steve Xydas, MD, Christopher.
Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage 

Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage 
Patient blood management in Europe

Patient blood management in Europe
Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit 

Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit 
Randomized controlled trial comparing the McGrath videolaryngoscope with the C-MAC videolaryngoscope in intubating adult patients with potential difficult.

Randomized controlled trial comparing the McGrath videolaryngoscope with the C-MAC videolaryngoscope in intubating adult patients with potential difficult.
Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study  Raimondo Ascione,

Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study  Raimondo Ascione,
Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus  C. Thorborg,

Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus  C. Thorborg,
R. Kaw, F. Chung, V. Pasupuleti, J. Mehta, P.C. Gay, A.V. Hernandez 

R. Kaw, F. Chung, V. Pasupuleti, J. Mehta, P.C. Gay, A.V. Hernandez 
Why is the surgical high-risk patient still at risk?

Why is the surgical high-risk patient still at risk?
LiQian Chen, MD, PhD, Arthur W

LiQian Chen, MD, PhD, Arthur W
Lidocaine use in ultrasound-guided femoral nerve block: what is the minimum effective anaesthetic concentration (MEAC90)?†  A.M. Taha, A.M. Abd-Elmaksoud 

Lidocaine use in ultrasound-guided femoral nerve block: what is the minimum effective anaesthetic concentration (MEAC90)?†  A.M. Taha, A.M. Abd-Elmaksoud 
K.-Y. Ho, W Tay, M.-C. Yeo, H Liu, S.-J. Yeo, S.-L. Chia, N.-N. Lo 

K.-Y. Ho, W Tay, M.-C. Yeo, H Liu, S.-J. Yeo, S.-L. Chia, N.-N. Lo 
D. M. Baron, H. Hochrieser, M. Posch, B. Metnitz, A. Rhodes, R. P

D. M. Baron, H. Hochrieser, M. Posch, B. Metnitz, A. Rhodes, R. P

Similar presentations

Ads by Google